Drug Profile
Beta lapachone
Alternative Names: ARQ 501; BRN 0181499; CO-501; NSC 26326; NSC 629749; R 1668; SL 11001Latest Information Update: 19 Jul 2023
Price :
$50
*
At a glance
- Originator Dana-Farber Cancer Institute
- Developer Merck & Co
- Class Antineoplastics; Eye disorder therapies; Naphthoquinones; Obesity therapies; Small molecules
- Mechanism of Action Apoptosis stimulants; E2F1 transcription factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Head and neck cancer; Leiomyoma; Pancreatic cancer; Solid tumours